Product/Service

Cell And Gene Therapy

Source: Mycenax
GettyImages-1339300422 CAR T-Cell Immunotherapy

Mycenax offers a comprehensive, one-stop CDMO service covering a broad spectrum of Allogeneic Cell and Gene Therapy (CGT) Products. We are committed to delivering total solutions that facilitate process development and GMP manufacturing of innovative CGT products, enabling our clients to expedite their products to market through our state-of-the-art, scalable closed-process platforms featuring automated and modular workflows. Mycenax's highlighted solutions include the provision of streamlined allogeneic cell sources as starting materials, ensuring our clients embark on their product development journey with the right cells.

Mycenax's Technology Platforms for Diverse Allogeneic CGT Products

  • Stem Cell Therapy
    • 3D MSC Manufacturing Platform
  • Immune Cell Therapy
    • NK Manufacturing Platform
    • gδ T Manufacturing Platform
  • CAR Gene Engineering Platform
    • CAR-NK
    • CAR-gδT
  • Cell Free